Viewing Study NCT06257056



Ignite Creation Date: 2024-05-06 @ 8:05 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06257056
Status: RECRUITING
Last Update Posted: 2024-06-03
First Post: 2024-02-05

Brief Title: Deep Brain Stimulation for Psychosis
Sponsor: Bradley Lega
Organization: University of Texas Southwestern Medical Center

Study Overview

Official Title: Closed Loop Neuromodulation for Treatment-refractory Schizophrenia A Pilot Study
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: There are three hypotheses proposed for this study 1 Participants will report no unanticipated serious adverse events during the eight months of treatment 2 Investigators will successfully model psychotic versus non-psychotic brain states using support vector machine SVM classifiers 3 Participants specific brain stimulation parameters can induce a change in the brain state consistent with non-psychotic states as measured by classifier output Hypotheses 1 2 and 3 address safety and tolerability efficacy and the putative mechanism of successful treatment

The overall objective is to use next generation Deep Brain Stimulation DBS combined with antecedent stereo electroencephalogram SEEG mapping to establish a new therapy for treatment-refractory schizophrenia given the limitations of current treatment modalities

The primary objective is to demonstrate safety of acute and chronic network guided stimulation for treatment-refractory schizophrenia

Exploratory Objectives

1 Use intracranial mapping SEEG combined with pharmacological manipulation of psychotic states to create a protocol for participant specific deep brain stimulation to treat treatment-refractory schizophrenia
2 Develop closed loop stimulation protocols to modify brain states during psychotic brain activity induced by low-dose ketamine administration
3 Investigate the use of mnemonic similarity to characterize brain networks related to symptoms of treatment-refractory schizophrenia
4 Treatment-related objectives Record a reduction in psychotic symptoms as well as an improvement in psychosocial function and cognition
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None